Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
2 papers
This review explains the fast-growing problem of so-called "legal highs", which are better called novel psychoactive substances or NPS. Unknown labs keep making slightly different chemicals to avoid bans, and this led to about 80 new substances being spotted in one year. The paper groups these drugs into five main…
This article reviews how drug laws in the United States are changing and clashing. Many states have moved to legalize or reduce penalties for marijuana and are testing whether psychedelics like psilocybin and MDMA can help with mental health. At the same time, some places have pushed back and even…
